In the present study, we show that breast cancer survivors (56 ± 6 years) exhibited higher levels of CD4+ central memory T cells and lower levels of CD8+ Naïve T cells compared to healthy women (45 ± 11 years). This evidence concerns the gene CD4 and breast carcinoma.